
Neutrophils are essential first responders of innate immunity, yet their dysregulation can shift protective inflammation toward tissue injury, thrombosis, and immune dysfunction. Rather than a uniform, short-lived population, neutrophils are highly plastic cells whose lifespan, metabolism, and cellular interactions are shaped by inflammatory and tissue-derived cues.
Our previous work identified complementary mechanisms linking neutrophil plasticity to disease. During acute inflammation, bone marrow neutrophils release lactate, which signals through endothelial GPR81, increases vascular permeability, and promotes neutrophil mobilization. In JAK2V617F myeloproliferative neoplasms, a chronic-inflammatory blood cancer, aged neutrophils evade macrophage-mediated clearance through CD24, accumulate in the bone marrow, and drive pathological neutrophil-megakaryocyte emperipolesis and fibrosis. In endotoxin-induced sepsis, we recently showed that broad neutrophil depletion reduces mortality. Together, our findings on neutrophil-derived lactate and pathological neutrophil-megakaryocyte interactions position sepsis as a powerful context where neutrophil ageing, metabolism, and cellular crosstalk may converge to drive pathology.
Sepsis is a life-threatening syndrome in which hyperinflammation, immunosuppression, and immunothrombosis coexist and evolve over time. Our research program will determine how aged neutrophils accumulate and promote vascular damage, organ dysfunction, and immune suppression; define how state-specific metabolic rewiring and neutrophil-derived lactate disrupt endothelial and immune homeostasis; and establish whether neutrophil-megakaryocyte emperipolesis drives platelet-mediated immunothrombosis and organ injury in sepsis.
By integrating neutrophil ageing, metabolism, and cellular-crosstalk into a state- and niche-resolved framework, this program will identify actionable checkpoints and diagnostic immune signatures that distinguish divergent sepsis trajectories, improve patient stratification, and enable mechanism-based interventions while preserving antimicrobial defense.